CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid

CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid

Source: 
CP Wire
snippet: 

The article discusses the concern over the number of deaths (244) and other adverse events linked to nuplazid. The drug was approved in April of 2016 as a much needed treatment for Parkinson's disease psychosis.